These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 26021985

  • 1. Circulating anti-citrullinated peptide antibodies, cytokines and genotype as biomarkers of response to disease-modifying antirheumatic drug therapy in early rheumatoid arthritis.
    Ally MM, Hodkinson B, Meyer PW, Musenge E, Tintinger GR, Tikly M, Anderson R.
    BMC Musculoskelet Disord; 2015 May 29; 16():130. PubMed ID: 26021985
    [Abstract] [Full Text] [Related]

  • 2. Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial.
    Kastbom A, Forslind K, Ernestam S, Geborek P, Karlsson JA, Petersson IF, Saevarsdottir S, Klareskog L, van Vollenhoven RF, Lundberg K.
    Ann Rheum Dis; 2016 Feb 29; 75(2):356-61. PubMed ID: 25550338
    [Abstract] [Full Text] [Related]

  • 3. Anti-citrullinated peptide antibodies and the progression of radiographic joint erosions in patients with early rheumatoid arthritis treated with FIN-RACo combination and single disease-modifying antirheumatic drug strategies.
    Mustila A, Korpela M, Haapala AM, Kautiainen H, Laasonen L, Möttönen T, Leirisalo-Repo M, Ilonen J, Järvenpää S, Luukkainen R, Hannonen P.
    Clin Exp Rheumatol; 2011 Feb 29; 29(3):500-5. PubMed ID: 21640044
    [Abstract] [Full Text] [Related]

  • 4. Associations of rheumatoid factor and anti-citrullinated peptide antibody with disease progression and treatment outcomes in patients with rheumatoid arthritis.
    Katchamart W, Koolvisoot A, Aromdee E, Chiowchanwesawakit P, Muengchan C.
    Rheumatol Int; 2015 Oct 29; 35(10):1693-9. PubMed ID: 25903353
    [Abstract] [Full Text] [Related]

  • 5. ACPA-positive and ACPA-negative rheumatoid arthritis differ in their requirements for combination DMARDs and corticosteroids: secondary analysis of a randomized controlled trial.
    Seegobin SD, Ma MH, Dahanayake C, Cope AP, Scott DL, Lewis CM, Scott IC.
    Arthritis Res Ther; 2014 Jan 16; 16(1):R13. PubMed ID: 24433430
    [Abstract] [Full Text] [Related]

  • 6. Antibodies against citrullinated peptides are associated with clinical and radiological outcomes in patients with early rheumatoid arthritis: a prospective longitudinal inception cohort study.
    Boman A, Brink M, Lundquist A, Hansson M, Mathsson-Alm L, Rönnelid J, Berglin E, Holmdahl R, Skriner K, Serre G, Klareskog L, Rantapää-Dahlqvist S.
    RMD Open; 2019 Jan 16; 5(2):e000946. PubMed ID: 31565241
    [Abstract] [Full Text] [Related]

  • 7. Serum RANKL levels associate with anti- citrullinated protein antibodies in early untreated rheumatoid arthritis and are modulated following methotrexate.
    Hensvold AH, Joshua V, Li W, Larkin M, Qureshi F, Israelsson L, Padyukov L, Lundberg K, Defranoux N, Saevarsdottir S, Catrina AI.
    Arthritis Res Ther; 2015 Sep 04; 17(1):239. PubMed ID: 26337028
    [Abstract] [Full Text] [Related]

  • 8. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP, van der Woude D, Ioan-Facsinay A, Levarht EW, Stoeken-Rijsbergen G, Huizinga TW, Toes RE, van der Helm-van Mil AH.
    Arthritis Rheum; 2009 Aug 04; 60(8):2232-41. PubMed ID: 19644872
    [Abstract] [Full Text] [Related]

  • 9. Complement system and rheumatoid arthritis: relationships with autoantibodies, serological, clinical features, and anti-TNF treatment.
    Di Muzio G, Perricone C, Ballanti E, Kroegler B, Greco E, Novelli L, Conigliaro P, Cipriani P, Giacomelli R, Perricone R.
    Int J Immunopathol Pharmacol; 2011 Aug 04; 24(2):357-66. PubMed ID: 21658310
    [Abstract] [Full Text] [Related]

  • 10. Missing Anticitrullinated Protein Antibody Does Not Affect Short-term Outcomes in Early Inflammatory Arthritis: From the Canadian Early Arthritis Cohort.
    Shu J, Bykerk VP, Boire G, Haraoui B, Hitchon C, Thorne JC, Tin D, Keystone EC, Pope JE, CATCH Investigators.
    J Rheumatol; 2015 Nov 04; 42(11):2023-8. PubMed ID: 26329342
    [Abstract] [Full Text] [Related]

  • 11. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
    Reyes-Castillo Z, Palafox-Sánchez CA, Parra-Rojas I, Martínez-Bonilla GE, del Toro-Arreola S, Ramírez-Dueñas MG, Ocampo-Bermudes G, Muñoz-Valle JF.
    Clin Exp Immunol; 2015 Nov 04; 182(2):119-31. PubMed ID: 26149185
    [Abstract] [Full Text] [Related]

  • 12. Changes in anti-citrullinated protein antibody isotype levels in relation to disease activity and response to treatment in early rheumatoid arthritis.
    Kastbom A, Roos Ljungberg K, Ziegelasch M, Wetterö J, Skogh T, Martinsson K.
    Clin Exp Immunol; 2018 Dec 04; 194(3):391-399. PubMed ID: 30136282
    [Abstract] [Full Text] [Related]

  • 13. The role of anti-citrullinated protein antibody reactivities in an inception cohort of patients with rheumatoid arthritis receiving treat-to-target therapy.
    Jonsson MK, Hensvold AH, Hansson M, Aga AB, Sexton J, Mathsson-Alm L, Cornillet M, Serre G, Lillegraven S, Fevang BS, Catrina AI, Haavardsholm EA.
    Arthritis Res Ther; 2018 Jul 13; 20(1):146. PubMed ID: 30001740
    [Abstract] [Full Text] [Related]

  • 14. Five-year outcomes of probable rheumatoid arthritis treated with methotrexate or placebo during the first year (the PROMPT study).
    van Aken J, Heimans L, Gillet-van Dongen H, Visser K, Ronday HK, Speyer I, Peeters AJ, Huizinga TW, Allaart CF.
    Ann Rheum Dis; 2014 Feb 13; 73(2):396-400. PubMed ID: 23334213
    [Abstract] [Full Text] [Related]

  • 15. Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies.
    Jiang X, Trouw LA, van Wesemael TJ, Shi J, Bengtsson C, Källberg H, Malmström V, Israelsson L, Hreggvidsdottir H, Verduijn W, Klareskog L, Alfredsson L, Huizinga TW, Toes RE, Lundberg K, van der Woude D.
    Ann Rheum Dis; 2014 Oct 13; 73(10):1761-8. PubMed ID: 24812286
    [Abstract] [Full Text] [Related]

  • 16. The effect of etanercept on anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis.
    Chen HA, Lin KC, Chen CH, Liao HT, Wang HP, Chang HN, Tsai CY, Chou CT.
    Ann Rheum Dis; 2006 Jan 13; 65(1):35-9. PubMed ID: 15975966
    [Abstract] [Full Text] [Related]

  • 17. B cell depletion with rituximab in patients with rheumatoid arthritis: Multiplex bead array reveals the kinetics of IgG and IgA antibodies to citrullinated antigens.
    Cambridge G, Leandro MJ, Lahey LJ, Fairhead T, Robinson WH, Sokolove J.
    J Autoimmun; 2016 Jun 13; 70():22-30. PubMed ID: 27055777
    [Abstract] [Full Text] [Related]

  • 18. Antibodies against cyclic citrullinated peptide don't decrease after 6 months of infliximab treatment in refractory rheumatoid arthritis.
    Kolarz B, Majdan M, Dryglewska M, Darmochwal-Kolarz D.
    Rheumatol Int; 2011 Nov 13; 31(11):1439-43. PubMed ID: 20473501
    [Abstract] [Full Text] [Related]

  • 19. The value of rheumatoid factor and anti-citrullinated protein antibodies as predictors of response to infliximab in rheumatoid arthritis: an exploratory study.
    Klaasen R, Cantaert T, Wijbrandts CA, Teitsma C, Gerlag DM, Out TA, de Nooijer MJ, Baeten D, Tak PP.
    Rheumatology (Oxford); 2011 Aug 13; 50(8):1487-93. PubMed ID: 21454308
    [Abstract] [Full Text] [Related]

  • 20. Synovial Immunophenotype and Anti-Citrullinated Peptide Antibodies in Rheumatoid Arthritis Patients: Relationship to Treatment Response and Radiologic Prognosis.
    Orr C, Najm A, Biniecka M, McGarry T, Ng CT, Young F, Fearon U, Veale DJ.
    Arthritis Rheumatol; 2017 Nov 13; 69(11):2114-2123. PubMed ID: 28732135
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.